EMA: Last Minute Decision in Europe. WHO Declares a New Public Health Emergency

By
Adrian Gabor
-

EMA Decision Last Time Europe WHO Declares Public Health Emergency

The EMA, the European Medicines Agency, has announced a last-minute decision for the hundreds of millions of Europeans who are part of the European Union, and this is because of the extremely worrying situation generated by the monkey pox, which was declared by the WHO as a public health emergency of international concern.

The EMA has decided that the Imvanex vaccine, now used to protect people against smallpox, can also be used to protect against monkeypox. We have been told repeatedly that smallpox vaccines can provide this protection, as can getting through the disease.

The EMA officially announced this decision because since monkeypox continues to spread in Europe, and the number of infected Europeans has already exceeded 10.000, much more than the public health agencies expected, it seems that much more measures are needed serious about protecting people now.

The WHO announced just a few tens of minutes ago that monkey pox is a public health emergency of international concern, a decision that many health experts were already anticipating, and this is because the number of cases, over 14.000 so far, is starting to shows that the virus is still spreading in many countries around the globe.

The WHO took this decision following the second meeting of an emergency committee whose purpose was to determine whether the intense transmission of monkeypox in Europe, and other countries around the world, is really so serious, and all in the context in which it was discovered that until now a certain group of people had the highest risk of infection.

The WHO has issued a set of recommendations for certain countries around the world, those with the highest number of cases of monkeypox infection, including the vaccination of hospital staff who are most exposed to a possible infections, but there is still no talk of mass vaccination against the virus.